• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Harry W. Flynn, Jr, MD
Miami, Fla

Travis A. Meredith, MD
St Louis, Mo

Arch Ophthalmol. 1996;114(8):1027-1028.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The recently published EVS presents the results of a randomized prospective clinical trial comparing 4 different initial treatment strategies for endophthalmitis following primary cataract surgery or secondary intraocular lens implantation.¹ Although the data represent a major contribution to our knowledge of the treatment outcomes of these approaches, the conclusions in the abstract go far beyond the data presented in the article.

Using the 4 major study outcomes (visual acuity 20/40, 20/100, 5/200, and media clarity), the EVS demonstrated no harmful effects in the 3-port pars plana vitrectomy group compared with the needle-tap or vitrectomy-biopsy group. Furthermore, the EVS data showed the following beneficial effects in the 3-port pars plana vitrectomy group compared with the needle-tap or vitrectomy-biopsy group: (1) improved media clarity at all follow-up examinations (statistically significant at 3 months); (2) lower rates of retinal detachment; (3) lower rates of persistent positive intraocular cultures (data presented at the . . . [Full Text PDF of this Article]

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?